Barclays Bank PLC (the “Issuer”) announced today that, in connection with its previously announced cash tender offers (each, ...

Teoxane, which holds a 6.2% stake in Revance and is a key customer of the Nashville, Tenn., company, had proposed buying the rest of the company for $3.60 a share after Crown reduced its planned ...

Emerson will acquire all outstanding shares of common stock of AspenTech not already owned by Emerson for $265/share pursuant to an all-cash tender offer. The transaction values the minority stake ...

SoftBank is in talks to invest up to $25 billion in OpenAI, which would make it the company’s biggest backer, CNBC has ...

Teoxane withdrew its $3.60 a share offer for Revance Therapeutics after Crown Labs raised its offer to $3.65. Revance ticked lower by 0.3% in premarket trading. Teoxane said that committed financing ...

According to a recent Bloomberg broadcast, SpaceX is now valued at about $350 billion (€336.2bn). This value has been ...

Securities maintained its Neutral rating on Revance Therapeutics (NASDAQ:RVNC) with a steady price target of $3.65, closely ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

The Scottish government’s hunt for a financial adviser for the nation’s debut bond sale is proving more costly than ...

The Scottish government’s hunt for a financial adviser for the nation’s debut bond sale is proving more costly than ...